Leading Edge of Cancer Research Symposium
 

Authors

Christopher L. Carroll, The University of Texas MD Anderson Cancer Center
Jan Reiling, The University of Texas MD Anderson Cancer Center
Jeffrey Kovacs, The University of Texas MD Anderson Cancer Center
Michael Bradley, The University of Texas MD Anderson Cancer Center
Meng He, The University of Texas MD Anderson Cancer Center
Nadima Uprety, The University of Texas MD Anderson Cancer Center
Michael Peoples, The University of Texas MD Anderson Cancer Center
Frederick Robinson, The University of Texas MD Anderson Cancer Center
Alessandro Carugo, The University of Texas MD Anderson Cancer Center
Michael Conner, The University of Texas MD Anderson Cancer Center
Christian Rodriguez, The University of Texas MD Anderson Cancer Center
Jennifer Bardenhagen, The University of Texas MD Anderson Cancer Center
Vijayan Ramaswamy, The University of Texas MD Anderson Cancer Center
Paul Leonard, The University of Texas MD Anderson Cancer Center
Zhijun Kang, The University of Texas MD Anderson Cancer Center
Catalina Suarez, The University of Texas MD Anderson Cancer Center
Teresa Perry, The University of Texas MD Anderson Cancer Center
Jing Han, The University of Texas MD Anderson Cancer Center
Sonal Fnu, The University of Texas MD Anderson Cancer Center
Nakia D. Spencer, The University of Texas MD Anderson Cancer Center
Guang Gao, The University of Texas MD Anderson Cancer Center
Angela Harris, The University of Texas MD Anderson Cancer Center
Alan Xu, The University of Texas MD Anderson Cancer Center
Jennifer Linares, The University of Texas MD Anderson Cancer Center
Thomas M. Quill, The University of Texas MD Anderson Cancer Center
Phuong Nguyen, The University of Texas MD Anderson Cancer Center
Qi Wu, The University of Texas MD Anderson Cancer Center
Stephanie T. Schmidt PhD, The University of Texas MD Anderson Cancer Center
Sahil Seth, The University of Texas MD Anderson Cancer Center
Christopher A. Bristow, The University of Texas MD Anderson Cancer Center
Norma Rogers, The University of Texas MD Anderson Cancer Center
Simon S. Yu, The University of Texas MD Anderson Cancer Center
Hannah E. Shepard, The University of Texas MD Anderson Cancer Center
Robert A. Mullinax, The University of Texas MD Anderson Cancer Center
Sabina A. Lorca, The University of Texas MD Anderson Cancer Center
Kang Le, The University of Texas MD Anderson Cancer Center
Reagan Lucas, The University of Texas MD Anderson Cancer Center
Sweta Mahaeshwari, The University of Texas MD Anderson Cancer Center
Sarah Joseph, The University of Texas MD Anderson Cancer Center
Ningping Feng, The University of Texas MD Anderson Cancer Center
Yongying Jiang, The University of Texas MD Anderson Cancer Center
Joe Marszalek, The University of Texas MD Anderson Cancer Center
Michael Soth, The University of Texas MD Anderson Cancer Center
Jason Cross, The University of Texas MD Anderson Cancer Center
Mary Geck Do, The University of Texas MD Anderson Cancer Center
M. Emilia Di Francesco, The University of Texas MD Anderson Cancer Center
Timothy P. Heffernan, The University of Texas MD Anderson Cancer Center
Philip Jones, The University of Texas MD Anderson Cancer Center

Files

Download

Download Poster (1.1 MB)

DOI

https://doi.org/10.52519/00046

Streaming Media

Publication Date

2022

Department

Institute for Applied Cancer Science

Research Category

The Patient is the Focus

Multi-disciplinary efforts to evaluate the therapeutic potential of CDK11, a novel transcription associated cyclin dependent kinase.

View Online

Share

COinS